Literature DB >> 20567618

Medulloblastoma in infants: the critical issues of the dilemma.

E Bouffet.   

Abstract

Entities:  

Keywords:  Medulloblastoma; chemotherapy; clinical trials; infants; radiation

Year:  2010        PMID： 20567618      PMCID： PMC2880900          DOI： 10.3747/co.v17i3.504

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  11 in total

1.  Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

Authors:  Susan N Chi; Sharon L Gardner; Adam S Levy; Edmond A Knopp; Douglas C Miller; Jeffrey H Wisoff; Howard L Weiner; Jonathan L Finlay
Journal:  J Clin Oncol       Date:  2004-12-15       Impact factor: 44.544

2.  Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.

Authors:  Jacques Grill; Christian Sainte-Rose; Anne Jouvet; Jean-Claude Gentet; Odile Lejars; Didier Frappaz; François Doz; Xavier Rialland; Fabienne Pichon; Anne-Isabelle Bertozzi; Pascal Chastagner; Dominique Couanet; Jean-Louis Habrand; Marie-Anne Raquin; Marie-Cécile Le Deley; Chantal Kalifa
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

3.  Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.

Authors:  W P Mason; A Grovas; S Halpern; I J Dunkel; J Garvin; G Heller; M Rosenblum; S Gardner; D Lyden; S Sands; D Puccetti; K Lindsley; T E Merchant; B O'Malley; L Bayer; M M Petriccione; J Allen; J L Finlay
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

4.  Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.

Authors:  J Russell Geyer; Richard Sposto; Mark Jennings; James M Boyett; Richard A Axtell; David Breiger; Emmett Broxson; Bernadine Donahue; Jonathan L Finlay; Joel W Goldwein; Linda A Heier; Dennis Johnson; Claire Mazewski; Douglas C Miller; Roger Packer; Diane Puccetti; Jerilynn Radcliffe; May Lin Tao; Tania Shiminski-Maher
Journal:  J Clin Oncol       Date:  2005-10-20       Impact factor: 44.544

5.  Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

Authors:  Stefan Rutkowski; Udo Bode; Frank Deinlein; Holger Ottensmeier; Monika Warmuth-Metz; Niels Soerensen; Norbert Graf; Angela Emser; Torsten Pietsch; Johannes E A Wolff; Rolf D Kortmann; Joachim Kuehl
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  Medulloblastoma in children under the age of three years: a retrospective Canadian review.

Authors:  Donna L Johnston; Daniel Keene; Ute Bartels; Anne-Sophie Carret; Bruce Crooks; David D Eisenstat; Chris Fryer; Lucie Lafay-Cousin; Valerie Larouche; Albert Moghrabi; Beverly Wilson; Shayna Zelcer; Mariana Silva; Josee Brossard; Eric Bouffet
Journal:  J Neurooncol       Date:  2009-01-31       Impact factor: 4.130

7.  Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.

Authors:  Girish Dhall; Howard Grodman; Lingyun Ji; Stephen Sands; Sharon Gardner; Ira J Dunkel; Geoffrey B McCowage; Blanca Diez; Jeffrey C Allen; Anjali Gopalan; Albert S Cornelius; Amanda Termuhlen; Minnie Abromowitch; Richard Sposto; Jonathan L Finlay
Journal:  Pediatr Blood Cancer       Date:  2008-06       Impact factor: 3.167

8.  Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.

Authors:  P K Duffner; M E Horowitz; J P Krischer; H S Friedman; P C Burger; M E Cohen; R A Sanford; R K Mulhern; H E James; C R Freeman
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

9.  Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study.

Authors:  P K Duffner; J P Krischer; M E Horowitz; M E Cohen; P C Burger; H S Friedman; L E Kun
Journal:  Ann Neurol       Date:  1998-09       Impact factor: 10.422

10.  Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma.

Authors:  L Lafay-Cousin; E Bouffet; C Hawkins; A Amid; A Huang; D J Mabbott
Journal:  Curr Oncol       Date:  2009-12       Impact factor: 3.677
View more
  4 in total

1.  Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N10-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose Methotrexate.

Authors:  Michael S Roberts; Nicholas S Selvo; Jessica K Roberts; Vinay M Daryani; Thandranese S Owens; K Elaine Harstead; Amar Gajjar; Clinton F Stewart
Journal:  J Liq Chromatogr Relat Technol       Date:  2016-10-10       Impact factor: 1.312

2.  Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas.

Authors:  Wan-Yee Teo; M Tarek Elghetany; Jianhe Shen; Tsz-Kwong Man; Xiaonan Li; Murali Chintagumpala; Jack Meng Fen Su; Robert Dauser; William Whitehead; Adekunle M Adesina; Ching C Lau
Journal:  J Neurooncol       Date:  2014-08-13       Impact factor: 4.130

Review 3.  Shared medical decision-making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young children.

Authors:  Deena Levine; Kenneth Cohen; David Wendler
Journal:  Pediatr Blood Cancer       Date:  2012-04-22       Impact factor: 3.167

4.  Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.

Authors:  Kee Kiat Yeo; Ashley S Margol; Rebekah J Kennedy; Long Hung; Nathan J Robison; Girish Dhall; Shahab Asgharzadeh
Journal:  J Neurooncol       Date:  2019-10-16       Impact factor: 4.130
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.